A case report of toxic epidermal necrolysis (TEN) in a patient with COVID-19 treated with hydroxychloroquine: Are these two partners in crime

被引：27

作者：

Rossi C.M. ^{[1
]}

Beretta F.N. ^{[2
]}

Traverso G. ^{[1
]}

Mancarella S. ^{[1
]}

Zenoni D. ^{[3
]}

机构：

[1] Dipartimento di Area Medica, U.O. Medicina Interna, ASST Nord Milano, Ospedale Edoardo Bassini, Via Massimo Gorki 50, Cinisello Balsamo (MI)

[2] Scuola di Specializzazione in Farmacia Ospedaliera, Università Degli Studi di Milano, Via L. Mangiagalli 25, Milan, MI

[3] U.O.C. Farmacia Interna, ASST Nord Milano, Ospedale Edoardo Bassini, Via Massimo Gorki 50, Cinisello Balsamo (MI)

来源：

Clinical and Molecular Allergy | / 18卷 / 1期

关键词：

Adverse Drug Reaction (ADR); ALDEN Algorithm; COVID; 19; Hydroxychloroquine; Pharmacovigilance; SARS-CoV-2; SCORTEN Score; Severe Cutaneous Adverse Reactions (SCAR); Stevens-Johnson Syndrome (S[!text type='JS']JS[!/text]); Toxic Epidermal Necrolysis (TEN);

D O I：

10.1186/s12948-020-00133-6

中图分类号：

学科分类号：

摘要：

Background: Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is the most Serious Cutaneous Adverse Reaction (SCAR) often with a fatal outcome. Coronavirus Disease (COVID-19) is caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-COV2) and is an emergent pandemic for which no cure exist at the moment. Several drugs have been tried often with scant clinical evidence and safety. Case presentation: Here we report the case of 78-years-old woman with cardiometabolic syndrome and COVID-19. A multidrug regimen including others hydroxychloroquine, antibiotics, dexamethasone and paracetamol, low-molecular-weight-heparin and potassium canrenoate was started. After almost 3 weeks, the patient started to display a violaceous rash initially involving the flexural folds atypical targetoid lesions and showing a very fast extension, blister formation and skin detachments of approximately 70% of the total body surface area and mucous membranes involvement consistent with toxic epidermal necrolysis (TEN). The ALDEN algorithm was calculated inserting all drugs given to the patient in the 28 days preceding the onset of the skin manifestations. The highest score retrieved was for hydroxychloroquine. Other less suspicious drugs were piperacillin/tazobactam, ceftriaxone and levofloxacin. Conclusions: To our knowledge, this is the first case of TEN in a patient suffering from COVID-19 probably associated with hydroxychloroquine. Given the activation of the immune system syndrome induced by the virus and the widespread off-label use of this drug, we suggest a careful monitoring of skin and mucous membranes in all COVID-19 positive patients treated with hydroxychloroquine in order to early detect early signs of toxicities. © 2020 The Author(s).

引用

共 43 条

[1]

Harr T., French L.E., Toxic epidermal necrolysis and Stevens-Johnson syndrome, Orphanet J Rare Dis, (2010)

[2]

Su S.C., Chung W.H., Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions, Toxins, (2013)

[3]

Rothan H.A., Byrareddy S.N., The epidemeology and pathogensis of coronavirus (Covid-19) outbreak, J Autoimmun, (2020)

[4]

Huang C., Et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, Cina, Lancet, (2019)

[5]

Stebbing J., Et al., COVID-19: Combining antiviral and anti-inflammatory treatments, Lancet, (2020)

[6]

Costanzo M., De Giglio M.A.R., Roviello G.N., SARS CoV-2: Recent Reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus, Curr Med Chem, (2020)

[7]

Yao X., Et al., In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), Clin Infect Dis, 2, pp. 1-25, (2020)

[8]

Cao B., Et al., A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19, N Engl J Med, (2020)

[9]

Van Kraaij T., Et al., Tocilizumab in severe COVID-19 pneumonia and concomitant cytokine release syndrome, Eur J Case Reports Intern Med, (2017)

[10]

Sassolas B., Et al., ALDEN, an algorithm for assessment of drug causality in stevens-johnson syndrome and toxic epidermal necrolysis: Comparison with case-control analysis, Clin Pharmacol Ther, (2010)

← 1 2 3 4 5 →